The 2027 call on the dollar
- The dollarlean down↑ 7 houses up↓ 13 houses down
A house counts on the side its newest cyclical or strategic view argues: for a theme moving the dollar that way, or against a theme moving it the other way.
Up: the themes behind it
- 22 housesUS yield advantage keeps the dollar strong against peers16 of 22 houses with a longer-term view disagree. All horizons: 24 of 49 (49%). Houses with a view: 22 banks · 10 independent research firms · 9 podcasts · 8 asset managers.
- 3 housesReserve-currency status keeps the dollar strong against the euro2 of 3 houses with a longer-term view disagree. All horizons: 8 of 11 (73%). Houses with a view: 4 banks · 3 independent research firms · 2 asset managers · 2 podcasts.
- 3 housesRiskPopulist gains in Europe push euro-area bonds and the euro down3 of 3 houses with a longer-term view flag it as material. All horizons: 7 of 8 (88%). Houses with a view: 6 banks · 1 independent research firm · 1 podcast.
Positioning
Source: CFTC Commitments of Traders; FinChiefs calculations. Report of 3 Nov 2026.
The numbers, free and updated daily
Also moving the dollar, all horizons
Themes on the dollar without enough longer-term houses yet, counted on every horizon.
Other markets in the 2027 outlook
Questions
What do research houses expect for the dollar in 2027?
7 houses with a longer-term view argue for a rise and 13 for a fall. The strongest case up: US yield advantage keeps the dollar strong against peers (16 of 22 houses with a longer-term view disagree). The strongest case down: US yield advantage keeps the dollar strong against peers (16 of 22 houses with a longer-term view disagree).
Which research houses are counted?
Banks, asset managers, independent research firms and podcasts whose published research FinChiefs indexes: one vote per house, its newest cyclical or strategic view on the dollar in the last 30 days. Types only on this page; members see each house by name.
Is this investment advice?
No. Themes summarise what research houses argue. FinChiefs takes no view of its own. Instruments shown are the ones research houses name, not selected or endorsed by FinChiefs. Not investment advice. No prices are shown and no instrument pays to appear.
The Daily Digest in your inbox
Every morning, what published research argued the day before: the cross-asset and macro read in full, then every market in a line.